Head and neck cancer predictive risk estimator to determine control and therapeutic outcomes of radiotherapy (HNC-PREDICTOR): development, international multi-institutional validation, and web implementation of clinic-ready model-based risk stratification for head and neck cancer

BACKGROUND: Personalised radiotherapy can improve treatment outcomes of patients with head and neck cancer (HNC), where currently a ‘one-dose-fits-all’ approach is the standard. The aim was to establish individualised outcome prediction based on multi-institutional international ‘big-data’ to facili...

Descripción completa

Detalles Bibliográficos
Autores principales: van Dijk, Lisanne V., Mohamed, Abdallah SR., Ahmed, Sara, Nipu, Nafiul, Marai, G. Elisabeta, Wahid, Kareem, Sijtsema, Nanna M., Gunn, Brandon, Garden, Adam S., Moreno, Amy, Hope, Andrew J., Langendijk, Johannes A., Fuller, Clifton D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9853413/
https://www.ncbi.nlm.nih.gov/pubmed/36442460
http://dx.doi.org/10.1016/j.ejca.2022.10.011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9853413/
https://www.ncbi.nlm.nih.gov/pubmed/36442460
http://dx.doi.org/10.1016/j.ejca.2022.10.011

Ejemplares similares